Heparin Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027
The global heparin market reached a value of US$ 6.9 Billion in 2021. Looking forward, IMARC Group expects the market to reach US$ 8.1 Billion by 2027, exhibiting a CAGR of 2.57% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Heparin, denoted by the chemical formula C12H19NO20S3, is a sulfur-containing polysaccharide that acts as an anticoagulant or a blood thinner. It prevents the formation of blood clots inside blood vessels and is used for the treatment of heart conditions and unstable angina. It is also used in post-surgeries as well as during dialysis and blood transfusion. Heparin is usually injected directly into the muscle or the veins to break up clots and maintain smooth fluidity of the blood. Some common side-effects of using heparin include easy bruising and itchy skin with redness.
The rising prevalence of various medical ailments such as deep vein thrombosis (DVT) and pulmonary embolism (PE) is one of the key factors driving the global market. Also, heparin has been proven to be an extremely effective drug for venous thromboembolism and cardiovascular disorders (CVDs), which is contributing significantly to its market growth. Furthermore, biopharmaceutical companies are developing innovative medicines to enhance the therapeutic potential of heparin and reduce its side-effects. Availability of synthetic and semi-synthetic heparin mimetics that assist in treating various cancers, coagulation and inflammatory diseases is significantly increasing the adoption of the product. The market is further driven by the various advancements in the field of carbohydrate synthesis, which include building block preparation, coupling reactions and the development of convergent strategies. Moreover, increasing government funding toward improving healthcare facilities and extensive research and development (R&D) activities to develop heparin with ultra-low molecular weight for utilization in chemotherapy are also creating a positive outlook for the market.
IMARC Group’s latest report provides a deep insight into the global heparin market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the heparin market in any manner.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global heparin market, along with forecasts at the global and regional level from 2022-2027. Our report has categorized the market based on product, source, mode of administration, application, end-user and distribution channel.
Breakup by Product:
Unfractionated Heparin
Low Molecular Weight Heparin (LMWH)
Ultra-Low Molecular Weight Heparin (ULMWH)
Breakup by Source:
Bovine
Porcine
Breakup by Mode of Administration:
Oral
Parenteral
Breakup by Application:
Atrial Fibrillation & Heart Attack
Stroke
Deep Vein Thrombosis (DVT)
Pulmonary Embolism (PE)
Others
Breakup by End-User:
Hospitals
Clinics
Homecare Settings
Ambulatory Surgical Centers
Others
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Stores
Others
Breakup by Region:
Europe
North America
Asia Pacific
Middle East and Africa
Latin America
Competitive Landscape:
The report has also analyzed the competitive landscape of the market with some of the key players being GlaxoSmithKline Plc, Shenzhen Hepalink Pharmaceutical Co., Ltd, Pfizer Inc., LEO Pharma A/S, Sanofi S.A., Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Aspen Holdings, Baxter International Inc., Hebei Changshan Biochemical Pharmaceutical Co. Ltd., Sandoz International GmbH, Opocrin S.p.A., Sichuan Deebio Pharmaceutical Co., Ltd. and Dongying Tiandong Pharmaceutical Co., Ltd.
Key Questions Answered in This Report:
How has the global heparin market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global heparin industry?
What are the key regional markets in the global heparin industry?
What is the breakup of the market based on the product?
What is the breakup of the market based on the source?
What is the breakup of the market based on the mode of administration?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end-user?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the global heparin industry?
What are the key driving factors and challenges in the global heparin industry?
What is the structure of the global heparin industry and who are the key players?
What is the degree of competition in the global heparin industry?
Heparin, denoted by the chemical formula C12H19NO20S3, is a sulfur-containing polysaccharide that acts as an anticoagulant or a blood thinner. It prevents the formation of blood clots inside blood vessels and is used for the treatment of heart conditions and unstable angina. It is also used in post-surgeries as well as during dialysis and blood transfusion. Heparin is usually injected directly into the muscle or the veins to break up clots and maintain smooth fluidity of the blood. Some common side-effects of using heparin include easy bruising and itchy skin with redness.
The rising prevalence of various medical ailments such as deep vein thrombosis (DVT) and pulmonary embolism (PE) is one of the key factors driving the global market. Also, heparin has been proven to be an extremely effective drug for venous thromboembolism and cardiovascular disorders (CVDs), which is contributing significantly to its market growth. Furthermore, biopharmaceutical companies are developing innovative medicines to enhance the therapeutic potential of heparin and reduce its side-effects. Availability of synthetic and semi-synthetic heparin mimetics that assist in treating various cancers, coagulation and inflammatory diseases is significantly increasing the adoption of the product. The market is further driven by the various advancements in the field of carbohydrate synthesis, which include building block preparation, coupling reactions and the development of convergent strategies. Moreover, increasing government funding toward improving healthcare facilities and extensive research and development (R&D) activities to develop heparin with ultra-low molecular weight for utilization in chemotherapy are also creating a positive outlook for the market.
IMARC Group’s latest report provides a deep insight into the global heparin market covering all its essential aspects. This ranges from macro overview of the market to micro details of the industry performance, recent trends, key market drivers and challenges, SWOT analysis, Porter’s five forces analysis, value chain analysis, etc. This report is a must-read for industry players, investors, researchers, consultants, business strategists, and all those who have any kind of stake or are planning to foray into the heparin market in any manner.
Key Market Segmentation:
IMARC Group provides an analysis of the key trends in each sub-segment of the global heparin market, along with forecasts at the global and regional level from 2022-2027. Our report has categorized the market based on product, source, mode of administration, application, end-user and distribution channel.
Breakup by Product:
Unfractionated Heparin
Low Molecular Weight Heparin (LMWH)
Ultra-Low Molecular Weight Heparin (ULMWH)
Breakup by Source:
Bovine
Porcine
Breakup by Mode of Administration:
Oral
Parenteral
Breakup by Application:
Atrial Fibrillation & Heart Attack
Stroke
Deep Vein Thrombosis (DVT)
Pulmonary Embolism (PE)
Others
Breakup by End-User:
Hospitals
Clinics
Homecare Settings
Ambulatory Surgical Centers
Others
Breakup by Distribution Channel:
Hospital Pharmacies
Retail Pharmacies
Drug Stores
Online Stores
Others
Breakup by Region:
Europe
North America
Asia Pacific
Middle East and Africa
Latin America
Competitive Landscape:
The report has also analyzed the competitive landscape of the market with some of the key players being GlaxoSmithKline Plc, Shenzhen Hepalink Pharmaceutical Co., Ltd, Pfizer Inc., LEO Pharma A/S, Sanofi S.A., Dr. Reddy’s Laboratories Ltd., Teva Pharmaceutical Industries Ltd., Aspen Holdings, Baxter International Inc., Hebei Changshan Biochemical Pharmaceutical Co. Ltd., Sandoz International GmbH, Opocrin S.p.A., Sichuan Deebio Pharmaceutical Co., Ltd. and Dongying Tiandong Pharmaceutical Co., Ltd.
Key Questions Answered in This Report:
How has the global heparin market performed so far and how will it perform in the coming years?
What has been the impact of COVID-19 on the global heparin industry?
What are the key regional markets in the global heparin industry?
What is the breakup of the market based on the product?
What is the breakup of the market based on the source?
What is the breakup of the market based on the mode of administration?
What is the breakup of the market based on the application?
What is the breakup of the market based on the end-user?
What is the breakup of the market based on the distribution channel?
What are the various stages in the value chain of the global heparin industry?
What are the key driving factors and challenges in the global heparin industry?
What is the structure of the global heparin industry and who are the key players?
What is the degree of competition in the global heparin industry?
1 PREFACE
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL HEPARIN MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Product
5.5 Market Breakup by Source
5.6 Market Breakup by Mode of Administration
5.7 Market Breakup by Application
5.8 Market Breakup by End-User
5.9 Market Breakup by Distribution Channel
5.10 Market Breakup by Region
5.11 Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1 Unfractionated Heparin
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Low Molecular Weight Heparin (LMWH)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Ultra-Low Molecular Weight Heparin (ULMWH)
6.3.1 Market Trends
6.3.2 Market Forecast
7 MARKET BREAKUP BY SOURCE
7.1 Bovine
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Porcine
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY MODE OF ADMINISTRATION
8.1 Oral
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Parenteral
8.2.1 Market Trends
8.2.2 Market Forecast
9 MARKET BREAKUP BY APPLICATION
9.1 Atrial Fibrillation & Heart Attack
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Stroke
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Deep Vein Thrombosis (DVT)
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Pulmonary Embolism (PE)
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast
10 MARKET BREAKUP BY END-USER
10.1 Hospitals
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Clinics
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Homecare Settings
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Ambulatory Surgical Centers
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Others
10.5.1 Market Trends
10.5.2 Market Forecast
11 MARKET BREAKUP BY DISTRIBUTION CHANNEL
11.1 Hospital Pharmacies
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Retail Pharmacies
11.2.1 Market Trends
11.2.2 Market Forecast
11.3 Drug Stores
11.3.1 Market Trends
11.3.2 Market Forecast
11.4 Online Stores
11.4.1 Market Trends
11.4.2 Market Forecast
11.5 Others
11.5.1 Market Trends
11.5.2 Market Forecast
12 MARKET BREAKUP BY REGION
12.1 Europe
12.1.1 Market Trends
12.1.2 Market Forecast
12.2 North America
12.2.1 Market Trends
12.2.2 Market Forecast
12.3 Asia Pacific
12.3.1 Market Trends
12.3.2 Market Forecast
12.4 Middle East and Africa
12.4.1 Market Trends
12.4.2 Market Forecast
12.5 Latin America
12.5.1 Market Trends
12.5.2 Market Forecast
13 SWOT ANALYSIS
13.1 Overview
13.2 Strengths
13.3 Weaknesses
13.4 Opportunities
13.5 Threats
14 VALUE CHAIN ANALYSIS
15 PORTER’S FIVE FORCES ANALYSIS
15.1 Overview
15.2 Bargaining Power of Buyers
15.3 Bargaining Power of Suppliers
15.4 Degree of Competition
15.5 Threat of New Entrants
15.6 Threat of Substitutes
16 PRICE ANALYSIS
17 COMPETITIVE LANDSCAPE
17.1 Market Structure
17.2 Key Players
17.3 Profiles of Key Players
17.3.1 GlaxoSmithKline Plc
17.3.2 Shenzhen Hepalink Pharmaceutical Co., Ltd
17.3.3 Pfizer Inc.
17.3.4 LEO Pharma A/S
17.3.5 Sanofi S.A.
17.3.6 Dr. Reddy’s Laboratories Ltd.
17.3.7 Teva Pharmaceutical Industries Ltd.
17.3.8 Aspen Holdings
17.3.9 Baxter International Inc.
17.3.10 Hebei Changshan Biochemical Pharmaceutical Co. Ltd.
17.3.11 Sandoz International GmbH
17.3.12 Opocrin S.p.A.
17.3.13 Sichuan Deebio Pharmaceutical Co., Ltd.
17.3.14 Dongying Tiandong Pharmaceutical Co., Ltd.
2 SCOPE AND METHODOLOGY
2.1 Objectives of the Study
2.2 Stakeholders
2.3 Data Sources
2.3.1 Primary Sources
2.3.2 Secondary Sources
2.4 Market Estimation
2.4.1 Bottom-Up Approach
2.4.2 Top-Down Approach
2.5 Forecasting Methodology
3 EXECUTIVE SUMMARY
4 INTRODUCTION
4.1 Overview
4.2 Key Industry Trends
5 GLOBAL HEPARIN MARKET
5.1 Market Overview
5.2 Market Performance
5.3 Impact of COVID-19
5.4 Market Breakup by Product
5.5 Market Breakup by Source
5.6 Market Breakup by Mode of Administration
5.7 Market Breakup by Application
5.8 Market Breakup by End-User
5.9 Market Breakup by Distribution Channel
5.10 Market Breakup by Region
5.11 Market Forecast
6 MARKET BREAKUP BY PRODUCT
6.1 Unfractionated Heparin
6.1.1 Market Trends
6.1.2 Market Forecast
6.2 Low Molecular Weight Heparin (LMWH)
6.2.1 Market Trends
6.2.2 Market Forecast
6.3 Ultra-Low Molecular Weight Heparin (ULMWH)
6.3.1 Market Trends
6.3.2 Market Forecast
7 MARKET BREAKUP BY SOURCE
7.1 Bovine
7.1.1 Market Trends
7.1.2 Market Forecast
7.2 Porcine
7.2.1 Market Trends
7.2.2 Market Forecast
8 MARKET BREAKUP BY MODE OF ADMINISTRATION
8.1 Oral
8.1.1 Market Trends
8.1.2 Market Forecast
8.2 Parenteral
8.2.1 Market Trends
8.2.2 Market Forecast
9 MARKET BREAKUP BY APPLICATION
9.1 Atrial Fibrillation & Heart Attack
9.1.1 Market Trends
9.1.2 Market Forecast
9.2 Stroke
9.2.1 Market Trends
9.2.2 Market Forecast
9.3 Deep Vein Thrombosis (DVT)
9.3.1 Market Trends
9.3.2 Market Forecast
9.4 Pulmonary Embolism (PE)
9.4.1 Market Trends
9.4.2 Market Forecast
9.5 Others
9.5.1 Market Trends
9.5.2 Market Forecast
10 MARKET BREAKUP BY END-USER
10.1 Hospitals
10.1.1 Market Trends
10.1.2 Market Forecast
10.2 Clinics
10.2.1 Market Trends
10.2.2 Market Forecast
10.3 Homecare Settings
10.3.1 Market Trends
10.3.2 Market Forecast
10.4 Ambulatory Surgical Centers
10.4.1 Market Trends
10.4.2 Market Forecast
10.5 Others
10.5.1 Market Trends
10.5.2 Market Forecast
11 MARKET BREAKUP BY DISTRIBUTION CHANNEL
11.1 Hospital Pharmacies
11.1.1 Market Trends
11.1.2 Market Forecast
11.2 Retail Pharmacies
11.2.1 Market Trends
11.2.2 Market Forecast
11.3 Drug Stores
11.3.1 Market Trends
11.3.2 Market Forecast
11.4 Online Stores
11.4.1 Market Trends
11.4.2 Market Forecast
11.5 Others
11.5.1 Market Trends
11.5.2 Market Forecast
12 MARKET BREAKUP BY REGION
12.1 Europe
12.1.1 Market Trends
12.1.2 Market Forecast
12.2 North America
12.2.1 Market Trends
12.2.2 Market Forecast
12.3 Asia Pacific
12.3.1 Market Trends
12.3.2 Market Forecast
12.4 Middle East and Africa
12.4.1 Market Trends
12.4.2 Market Forecast
12.5 Latin America
12.5.1 Market Trends
12.5.2 Market Forecast
13 SWOT ANALYSIS
13.1 Overview
13.2 Strengths
13.3 Weaknesses
13.4 Opportunities
13.5 Threats
14 VALUE CHAIN ANALYSIS
15 PORTER’S FIVE FORCES ANALYSIS
15.1 Overview
15.2 Bargaining Power of Buyers
15.3 Bargaining Power of Suppliers
15.4 Degree of Competition
15.5 Threat of New Entrants
15.6 Threat of Substitutes
16 PRICE ANALYSIS
17 COMPETITIVE LANDSCAPE
17.1 Market Structure
17.2 Key Players
17.3 Profiles of Key Players
17.3.1 GlaxoSmithKline Plc
17.3.2 Shenzhen Hepalink Pharmaceutical Co., Ltd
17.3.3 Pfizer Inc.
17.3.4 LEO Pharma A/S
17.3.5 Sanofi S.A.
17.3.6 Dr. Reddy’s Laboratories Ltd.
17.3.7 Teva Pharmaceutical Industries Ltd.
17.3.8 Aspen Holdings
17.3.9 Baxter International Inc.
17.3.10 Hebei Changshan Biochemical Pharmaceutical Co. Ltd.
17.3.11 Sandoz International GmbH
17.3.12 Opocrin S.p.A.
17.3.13 Sichuan Deebio Pharmaceutical Co., Ltd.
17.3.14 Dongying Tiandong Pharmaceutical Co., Ltd.
LIST OF TABLES
Table 1: Global: Heparin Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Heparin Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Heparin Market Forecast: Breakup by Source (in Million US$), 2022-2027
Table 4: Global: Heparin Market Forecast: Breakup by Mode of Administration (in Million US$), 2022-2027
Table 5: Global: Heparin Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 6: Global: Heparin Market Forecast: Breakup by End-User (in Million US$), 2022-2027
Table 7: Global: Heparin Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 8: Global: Heparin Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 9: Global: Heparin Market Structure
Table 10: Global: Heparin Market: Key Players
Table 1: Global: Heparin Market: Key Industry Highlights, 2021 and 2027
Table 2: Global: Heparin Market Forecast: Breakup by Product (in Million US$), 2022-2027
Table 3: Global: Heparin Market Forecast: Breakup by Source (in Million US$), 2022-2027
Table 4: Global: Heparin Market Forecast: Breakup by Mode of Administration (in Million US$), 2022-2027
Table 5: Global: Heparin Market Forecast: Breakup by Application (in Million US$), 2022-2027
Table 6: Global: Heparin Market Forecast: Breakup by End-User (in Million US$), 2022-2027
Table 7: Global: Heparin Market Forecast: Breakup by Distribution Channel (in Million US$), 2022-2027
Table 8: Global: Heparin Market Forecast: Breakup by Region (in Million US$), 2022-2027
Table 9: Global: Heparin Market Structure
Table 10: Global: Heparin Market: Key Players
LIST OF FIGURES
Figure 1: Global: Heparin Market: Major Drivers and Challenges
Figure 2: Global: Heparin Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Heparin Market: Breakup by Product (in %), 2021
Figure 4: Global: Heparin Market: Breakup by Source (in %), 2021
Figure 5: Global: Heparin Market: Breakup by Mode of Administration (in %), 2021
Figure 6: Global: Heparin Market: Breakup by Application (in %), 2021
Figure 7: Global: Heparin Market: Breakup by End-User (in %), 2021
Figure 8: Global: Heparin Market: Breakup by Distribution Channel (in %), 2021
Figure 9: Global: Heparin Market: Breakup by Region (in %), 2021
Figure 10: Global: Heparin Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 11: Global: Heparin Industry: SWOT Analysis
Figure 12: Global: Heparin Industry: Value Chain Analysis
Figure 13: Global: Heparin Industry: Porter’s Five Forces Analysis
Figure 14: Global: Heparin (Unfractionated) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Heparin (Unfractionated) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Heparin (Low Molecular Weight) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Heparin (Low Molecular Weight) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Heparin (Ultra-Low Molecular Weight) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Heparin (Ultra-Low Molecular Weight) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Heparin (Bovine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Heparin (Bovine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Heparin (Porcine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Heparin (Porcine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Heparin (Oral) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Heparin (Oral) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Heparin (Parenteral) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Heparin (Parenteral) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Heparin (Atrial Fibrillation & Heart Attack) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Heparin (Atrial Fibrillation & Heart Attack) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Heparin (Stroke) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Heparin (Stroke) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Heparin (Deep Vein Thrombosis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Heparin (Deep Vein Thrombosis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Heparin (Pulmonary Embolism) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Heparin (Pulmonary Embolism) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Global: Heparin (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Global: Heparin (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Global: Heparin (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Global: Heparin (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Global: Heparin (Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Global: Heparin (Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Global: Heparin (Homecare Settings) Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Global: Heparin (Homecare Settings) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Global: Heparin (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Global: Heparin (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Global: Heparin (Other End-Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Global: Heparin (Other End-Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Global: Heparin Market: Sales through Hospital Pharmacies (in Million US$), 2016 & 2021
Figure 49: Global: Heparin Market Forecast: Sales through Hospital Pharmacies (in Million US$), 2022-2027
Figure 50: Global: Heparin Market: Sales through Retail Pharmacies (in Million US$), 2016 & 2021
Figure 51: Global: Heparin Market Forecast: Sales through Retail Pharmacies (in Million US$), 2022-2027
Figure 52: Global: Heparin Market: Sales through Drug Stores (in Million US$), 2016 & 2021
Figure 53: Global: Heparin Market Forecast: Sales through Drug Stores (in Million US$), 2022-2027
Figure 54: Global: Heparin Market: Sales through Online Stores (in Million US$), 2016 & 2021
Figure 55: Global: Heparin Market Forecast: Sales through Online Stores (in Million US$), 2022-2027
Figure 56: Global: Heparin Market: Sales through Other Distribution Channels (in Million US$), 2016 & 2021
Figure 57: Global: Heparin Market Forecast: Sales through Other Distribution Channels (in Million US$), 2022-2027
Figure 58: Europe: Heparin Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Europe: Heparin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: North America: Heparin Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: North America: Heparin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Asia Pacific: Heparin Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Asia Pacific: Heparin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Middle East and Africa: Heparin Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Middle East and Africa: Heparin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Latin America: Heparin Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Latin America: Heparin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 1: Global: Heparin Market: Major Drivers and Challenges
Figure 2: Global: Heparin Market: Sales Value (in Billion US$), 2016-2021
Figure 3: Global: Heparin Market: Breakup by Product (in %), 2021
Figure 4: Global: Heparin Market: Breakup by Source (in %), 2021
Figure 5: Global: Heparin Market: Breakup by Mode of Administration (in %), 2021
Figure 6: Global: Heparin Market: Breakup by Application (in %), 2021
Figure 7: Global: Heparin Market: Breakup by End-User (in %), 2021
Figure 8: Global: Heparin Market: Breakup by Distribution Channel (in %), 2021
Figure 9: Global: Heparin Market: Breakup by Region (in %), 2021
Figure 10: Global: Heparin Market Forecast: Sales Value (in Billion US$), 2022-2027
Figure 11: Global: Heparin Industry: SWOT Analysis
Figure 12: Global: Heparin Industry: Value Chain Analysis
Figure 13: Global: Heparin Industry: Porter’s Five Forces Analysis
Figure 14: Global: Heparin (Unfractionated) Market: Sales Value (in Million US$), 2016 & 2021
Figure 15: Global: Heparin (Unfractionated) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 16: Global: Heparin (Low Molecular Weight) Market: Sales Value (in Million US$), 2016 & 2021
Figure 17: Global: Heparin (Low Molecular Weight) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 18: Global: Heparin (Ultra-Low Molecular Weight) Market: Sales Value (in Million US$), 2016 & 2021
Figure 19: Global: Heparin (Ultra-Low Molecular Weight) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 20: Global: Heparin (Bovine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 21: Global: Heparin (Bovine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 22: Global: Heparin (Porcine) Market: Sales Value (in Million US$), 2016 & 2021
Figure 23: Global: Heparin (Porcine) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 24: Global: Heparin (Oral) Market: Sales Value (in Million US$), 2016 & 2021
Figure 25: Global: Heparin (Oral) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 26: Global: Heparin (Parenteral) Market: Sales Value (in Million US$), 2016 & 2021
Figure 27: Global: Heparin (Parenteral) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 28: Global: Heparin (Atrial Fibrillation & Heart Attack) Market: Sales Value (in Million US$), 2016 & 2021
Figure 29: Global: Heparin (Atrial Fibrillation & Heart Attack) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 30: Global: Heparin (Stroke) Market: Sales Value (in Million US$), 2016 & 2021
Figure 31: Global: Heparin (Stroke) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 32: Global: Heparin (Deep Vein Thrombosis) Market: Sales Value (in Million US$), 2016 & 2021
Figure 33: Global: Heparin (Deep Vein Thrombosis) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 34: Global: Heparin (Pulmonary Embolism) Market: Sales Value (in Million US$), 2016 & 2021
Figure 35: Global: Heparin (Pulmonary Embolism) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 36: Global: Heparin (Other Applications) Market: Sales Value (in Million US$), 2016 & 2021
Figure 37: Global: Heparin (Other Applications) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 38: Global: Heparin (Hospitals) Market: Sales Value (in Million US$), 2016 & 2021
Figure 39: Global: Heparin (Hospitals) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 40: Global: Heparin (Clinics) Market: Sales Value (in Million US$), 2016 & 2021
Figure 41: Global: Heparin (Clinics) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 42: Global: Heparin (Homecare Settings) Market: Sales Value (in Million US$), 2016 & 2021
Figure 43: Global: Heparin (Homecare Settings) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 44: Global: Heparin (Ambulatory Surgical Centers) Market: Sales Value (in Million US$), 2016 & 2021
Figure 45: Global: Heparin (Ambulatory Surgical Centers) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 46: Global: Heparin (Other End-Users) Market: Sales Value (in Million US$), 2016 & 2021
Figure 47: Global: Heparin (Other End-Users) Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 48: Global: Heparin Market: Sales through Hospital Pharmacies (in Million US$), 2016 & 2021
Figure 49: Global: Heparin Market Forecast: Sales through Hospital Pharmacies (in Million US$), 2022-2027
Figure 50: Global: Heparin Market: Sales through Retail Pharmacies (in Million US$), 2016 & 2021
Figure 51: Global: Heparin Market Forecast: Sales through Retail Pharmacies (in Million US$), 2022-2027
Figure 52: Global: Heparin Market: Sales through Drug Stores (in Million US$), 2016 & 2021
Figure 53: Global: Heparin Market Forecast: Sales through Drug Stores (in Million US$), 2022-2027
Figure 54: Global: Heparin Market: Sales through Online Stores (in Million US$), 2016 & 2021
Figure 55: Global: Heparin Market Forecast: Sales through Online Stores (in Million US$), 2022-2027
Figure 56: Global: Heparin Market: Sales through Other Distribution Channels (in Million US$), 2016 & 2021
Figure 57: Global: Heparin Market Forecast: Sales through Other Distribution Channels (in Million US$), 2022-2027
Figure 58: Europe: Heparin Market: Sales Value (in Million US$), 2016 & 2021
Figure 59: Europe: Heparin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 60: North America: Heparin Market: Sales Value (in Million US$), 2016 & 2021
Figure 61: North America: Heparin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 62: Asia Pacific: Heparin Market: Sales Value (in Million US$), 2016 & 2021
Figure 63: Asia Pacific: Heparin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 64: Middle East and Africa: Heparin Market: Sales Value (in Million US$), 2016 & 2021
Figure 65: Middle East and Africa: Heparin Market Forecast: Sales Value (in Million US$), 2022-2027
Figure 66: Latin America: Heparin Market: Sales Value (in Million US$), 2016 & 2021
Figure 67: Latin America: Heparin Market Forecast: Sales Value (in Million US$), 2022-2027
